Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol vaginal tablets for cervical ripening and labor induction at term
ChiCTR2300068989Phase 4Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of misoprostol in pregnancy, sponsored by Peking University First Hospital. Primary endpoint: Adverse events. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
misoprostol
03
Conditions
pregnancy
Beyond the preview
Go deeper on ChiCTR2300068989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068989.